NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmaEssentia Corporation (TWO: 6446)

 
6446 Technical Analysis
5
As on 26th Mar 2024 6446 STOCK Price closed @ 318.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 429.80 & Strong Sell for SHORT-TERM with Stoploss of 501.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6446STOCK Price

Open 328.00 Change Price %
High 328.00 1 Day -7.50 -2.30
Low 316.00 1 Week -8.50 -2.60
Close 318.00 1 Month 4.00 1.27
Volume 1354347 1 Year -258.00 -44.79
52 Week High 591.00 | 52 Week Low 283.00
 
TWO Taiwan Most Active Stocks
3128 44.15 -2.11%
3323 37.30 5.82%
6274 232.50 2.20%
1815 35.65 -1.52%
3211 224.50 -0.66%
4931 105.50 9.78%
5498 12.25 9.87%
4979 184.00 2.22%
4991 119.50 9.63%
5483 92.50 1.31%
 
TWO Taiwan Top Gainers Stocks
3297 58.70 9.93%
6130 42.75 9.90%
3625 15.55 9.89%
5498 12.25 9.87%
6217 29.60 9.83%
4931 105.50 9.78%
6568 142.00 9.65%
4991 119.50 9.63%
3713 22.40 9.00%
4804 6.20 6.90%
 
TWO Taiwan Top Losers Stocks
2230 107.00 -13.71%
2230 107.00 -13.71%
2230 107.00 -13.71%
3202 3.96 -10.00%
6292 48.55 -8.05%
5315 20.95 -7.51%
3122 27.15 -5.89%
3609 50.10 -5.29%
4729 19.00 -5.00%
1813 15.10 -4.13%
 
 
6446
Daily Charts
6446
Intraday Charts
Whats New @
Bazaartrend
6446
Free Analysis
 
6446 Important Levels Intraday
RESISTANCE341.12
RESISTANCE333.71
RESISTANCE329.12
RESISTANCE324.54
SUPPORT311.46
SUPPORT306.88
SUPPORT302.29
SUPPORT294.88
 
6446 Forecast July 2025
4th UP Forecast680.28
3rd UP Forecast564.09
2nd UP Forecast492.28
1st UP Forecast420.46
1st DOWN Forecast215.54
2nd DOWN Forecast143.72
3rd DOWN Forecast71.91
4th DOWN Forecast-44.28
 
6446 Weekly Forecast
4th UP Forecast555.02
3rd UP Forecast479.01
2nd UP Forecast432.02
1st UP Forecast385.04
1st DOWN Forecast250.97
2nd DOWN Forecast203.98
3rd DOWN Forecast156.99
4th DOWN Forecast80.98
 
6446 Forecast2025
4th UP Forecast942.35
3rd UP Forecast742.12
2nd UP Forecast618.35
1st UP Forecast494.58
1st DOWN Forecast141.42
2nd DOWN Forecast17.65
3rd DOWN Forecast-106.12
4th DOWN Forecast-306.35
 
 
6446 Other Details
Segment EQ
Market Capital 25268811776.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6446 Address
6446
 
6446 Latest News
 
Your Comments and Response on PharmaEssentia Corporation
 
6446 Business Profile
PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include ropeginterferon alfa-2b that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company has a research collaboration agreement with Axis Therapeutics Limite for the development of T Cell Receptor-T therapy based on the T cell receptor affinity enhancing specific T cell therapy technology platform. PharmaEssentia Corporation was founded in 2003 and is headquartered in Taipei, Taiwan. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service